Navigation Links
Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call
Date:7/14/2009

HAYWARD, Calif., July 14 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that it will release its financial results for the second quarter ended June 30, 2009 after the market close on Thursday, July 30, 2009. The Company will also host a conference call and webcast on Thursday, July 30, 2009, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate developments. The dial-in number for the conference call is 877-941-1848 for domestic participants and 480-629-9722 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will remain accessible for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3000 for international callers. Both callers will need to use the Passcode 4093352#. To access the live webcast of the call, go to Solta Medical's website at www.solta.com and click on Investor Relations. An archived webcast will also be available at www.solta.com.

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians.

The company offers products to address aging skin under the industry's two premier brands: Thermage(R) and Fraxel(R). Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, over one million Thermage
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
2. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
3. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
4. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
5. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting
6. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
7. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
8. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
9. Solta Medical, Inc. Announces Preliminary Financial Results for the Fourth Quarter of 2008
10. Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
11. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... ... Text results have been impressive so far". , Mr Cauchois attributes the ... Winscribe's French sales partner Dicma and the healthcare technology offered by Winscribe's platform. ...
(Date:8/3/2015)... ... 2015 , ... While the pace of the economic recovery since the 2008 has been subject ... growth trajectory for the last six years. Unemployment has dropped from a 2009 high of ... percent growth rate in 2014, the U.S. stock market is at an all time high, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Zeiter’s Septic ... As a family owned and operated business, Zeiter’s Septic has been serving the ... leader in septic installations because of their continued training and perseverance to provide ...
(Date:8/3/2015)... ... 2015 , ... Code , an industry leader of image-based barcode reading ... Reader accessory that enables a wireless connection between the CR5000 and a ... of barcode reading applications with iPads, Galaxy Tabs, and many other products that lack ...
(Date:8/3/2015)... ... August 03, 2015 , ... Bayer has agreed to pay ... claims in which a claimant alleged to have suffered an arterial blood clot including ... control pills, Yaz, Yasmin and Ocella, has been ongoing for well-over five years. In ...
Breaking Medicine News(10 mins):Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2
... 10 "The Senate compromise version of H.R. 1, ... no relief to the thousands of state and local ... economic downturn - including those who work in laboratories," ... Public Health Laboratories. "Unfortunately, the Senate has decided that ...
... Inc. (NYSE: NTY ) ( www.NBTY.com ), a leading global manufacturer and marketer of nutritional supplements, today announced the following preliminary unaudited ... NET SALES, ... FOR THE ... ($In Millions), ...
... Potential sale increases focus on growing core businessesCHICAGO, Feb. ... that it has reached an agreement in principle, subject ... to sell its Medication Services business. Closing of the ... conditions, but no assurances can be given that a ...
... as HPV tweak their DNA to escape detection, study ... of cancer-related viruses may actually change to disguise themselves from ... international team of scientists studied the entire genomes of three ... hepatitis B. Each of these pathogens can progress into cancer ...
... even if you stop taking the drug, study finds , , ... aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to reduce ... cancer. , That,s the conclusion of a new study of ... clear, and arguably proven, that NSAID drugs do interfere with ...
... of the Center for Research on Minority Health ... Member for NPAF and PAF, Honored for His ... Feb. 10 The National Patient Advocate Foundation ... that a member of the Foundations, Executive Boards, ...
Cached Medicine News:Health News:Laid Off Public Health Workers Excluded From Senate Stimulus, Governmental Health Laboratories Slammed by Recession 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results for January 2009 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results for January 2009 3Health News:Allscripts Announces Agreement in Principle to Sell Its Medication Services Business 2Health News:Allscripts Announces Agreement in Principle to Sell Its Medication Services Business 3Health News:Genes Help Cancer-Linked Viruses Elude Immune System 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 3Health News:Executive Board Member of National Patient Advocate Foundation, Patient Advocate Foundation Receives National Institutes of Health 2008 Health Disparities Excellence Award 2Health News:Executive Board Member of National Patient Advocate Foundation, Patient Advocate Foundation Receives National Institutes of Health 2008 Health Disparities Excellence Award 3
(Date:8/3/2015)... 3, 2015 Cooperative ... military surgical research and top-tier universities for ... to severe wound treatments for critical-care patients ... medicine and tissue-engineered skin substitute advancements.  Biotech ... in focus are Amarantus Bioscience Holdings, Inc. ...
(Date:8/3/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), maker of ... Andrew J. Whelan , President will be interviewed ... Business" at 9am EDT on Wednesday, August 5 th ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. ... the company,s flagship product, ActiPatch Therapy, is achieving in ...
(Date:8/3/2015)... , Aug. 3, 2015  Charleston Laboratories, ... of its second clinical development program with a ... CL-H1T.  CL-H1T contains fast-dissolving promethazine ... developed as a treatment for migraine headache pain ... "Many patients with migraine headaches also suffer ...
Breaking Medicine Technology:Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2
... Md., Nov. 28, 2011 PharmAthene, Inc. (NYSE Amex: ... countermeasures against biological and chemical threats, announced today that ... present at the Piper Jaffray 23rd Annual Healthcare Conference ... Richman will also be available to participate in one-on-one ...
... Conn., Nov. 28, 2011 Gaylord Sleep Medicine now ... their Glastonbury, Guilford, North Haven and Trumbull locations. ... new Sleep Apnea Management program has expanded to offer ... patient needs. Originally designed to improve PAP compliance, the ...
Cached Medicine Technology:PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011 2Gaylord Sleep Medicine Expands Sleep Apnea Management Program 2
Replacement bulb for Vibratome light system....
The V-Block adapter is designed to allow round posts to be placed in the Vibratome vice....
This is a perfect tool for retrieving free floating sections from the Vibratome bath....
... includes everything from the care package ... Spare Fluorescent Bulb, additional Vibratome Feather ... and a Specimen Tray. ... 1/2" speciment mounts, replacement rotating mounts, ...
Medicine Products: